Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
0 this month

Showing 10361–10380 of 17,529 recalls

March 7, 2017· A&H Focal Inc.

Recalled Item: Black Ant capsules

The Issue: Marked Without An Approved NDA/ANDA: FDA analysis found

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 7, 2017· A&H Focal Inc.

Recalled Item: Tiger King tablets

The Issue: Marked Without An Approved NDA/ANDA: FDA analysis found

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 7, 2017· A&H Focal Inc.

Recalled Item: YANSHIJIAONANG capsules

The Issue: Marked Without An Approved NDA/ANDA: FDA analysis found

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
March 7, 2017· A&H Focal Inc.

Recalled Item: DADIYONGSHI XIANGGANGTIANLONGSHENGWU tablets

The Issue: Marked Without An Approved NDA/ANDA: FDA analysis found

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
March 7, 2017· A&H Focal Inc.

Recalled Item: Miraculous Evil Root capsules

The Issue: Marked Without An Approved NDA/ANDA: FDA analysis found

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
March 7, 2017· A&H Focal Inc.

Recalled Item: Clalis capsules

The Issue: Marked Without An Approved NDA/ANDA: FDA analysis found

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
March 7, 2017· A&H Focal Inc.

Recalled Item: GOLD VIGRA capsules

The Issue: Marked Without An Approved NDA/ANDA: FDA analysis found

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
March 7, 2017· A&H Focal Inc.

Recalled Item: HARD TEN DAYS capsules

The Issue: Marked Without An Approved NDA/ANDA: FDA analysis found

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 7, 2017· A&H Focal Inc.

Recalled Item: MAX MAN capsules

The Issue: Marked Without An Approved NDA/ANDA: FDA analysis found

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 7, 2017· A&H Focal Inc.

Recalled Item: GERMANY NIUBIAN tablets

The Issue: Marked Without An Approved NDA/ANDA: FDA analysis found

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
March 7, 2017· A&H Focal Inc.

Recalled Item: STREE OVERLORD capsules

The Issue: Marked Without An Approved NDA/ANDA: FDA analysis found

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 7, 2017· A&H Focal Inc.

Recalled Item: MACA gold tablets

The Issue: Marked Without An Approved NDA/ANDA: FDA analysis found

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
March 7, 2017· Alvogen, Inc

Recalled Item: Nifedipine Extended-Release Tablets

The Issue: Cross Contamination with another product:residual powder found in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
March 7, 2017· Alvogen, Inc

Recalled Item: Nifedipine Extended-Release Tablets

The Issue: Cross Contamination with another product:residual powder found in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
March 7, 2017· Alvogen, Inc

Recalled Item: Adalat CC (nifedipine) Extended Release Tablets 30 mg

The Issue: Cross Contamination with another product:residual powder found in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
March 7, 2017· Alvogen, Inc

Recalled Item: Adalat CC (nifedipine) Extended Release Tablets

The Issue: Cross Contamination with another product:residual powder found in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
March 7, 2017· Alvogen, Inc

Recalled Item: Nifedipine Extended-Release Tablets

The Issue: Cross Contamination with another product:residual powder found in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
March 7, 2017· Alvogen, Inc

Recalled Item: Adalat CC (nifedipine) Extended-Release Tablets

The Issue: Cross Contamination with another product:residual powder found in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
March 7, 2017· Alvogen, Inc

Recalled Item: Adalat CC (nifedipine) Extended-Release Tablets

The Issue: Cross Contamination with another product:residual powder found in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
March 7, 2017· Alvogen, Inc

Recalled Item: Adalat CC (nifedipine) Extended-Release Tablets

The Issue: Cross Contamination with another product:residual powder found in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund